Alkermes Plc (ALKS)
46.20
-0.65
(-1.39%)
USD |
NASDAQ |
Nov 19, 16:00
46.20
0.00 (0.00%)
After-Hours: 16:58
Alkermes Price : 46.20 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 45.26 | 47.06 | 45.25 | 46.85 | 1.409M |
| Nov 17, 2026 | 46.37 | 46.64 | 45.10 | 45.45 | 932618.0 |
| Nov 16, 2026 | 47.02 | 47.76 | 46.26 | 46.53 | 1.052M |
| Nov 13, 2026 | 46.83 | 47.44 | 46.10 | 47.03 | 1.430M |
| Nov 12, 2026 | 46.00 | 48.30 | 45.27 | 46.98 | 3.126M |
| Nov 11, 2026 | 46.47 | 48.00 | 46.08 | 47.89 | 1.032M |
| Nov 10, 2026 | 45.67 | 46.57 | 45.35 | 46.47 | 1.036M |
| Nov 09, 2026 | 46.10 | 47.07 | 45.59 | 46.17 | 1.709M |
| Nov 06, 2026 | 44.19 | 45.94 | 44.07 | 45.90 | 1.673M |
| Nov 05, 2026 | 45.96 | 46.55 | 44.42 | 44.54 | 1.944M |
| Nov 04, 2026 | 46.23 | 47.01 | 44.58 | 45.89 | 2.179M |
| Nov 03, 2026 | 46.17 | 47.43 | 45.22 | 45.69 | 2.329M |
| Nov 02, 2026 | 45.59 | 45.94 | 44.48 | 44.89 | 2.162M |
| Oct 30, 2026 | 45.67 | 46.35 | 44.78 | 45.34 | 1.113M |
| Oct 29, 2026 | 46.01 | 46.38 | 45.18 | 45.37 | 1.427M |
| Oct 28, 2026 | 43.66 | 45.29 | 43.45 | 45.25 | 1.440M |
| Oct 27, 2026 | 44.34 | 45.02 | 43.99 | 44.32 | 1.322M |
| Oct 26, 2026 | 44.11 | 44.84 | 43.60 | 44.44 | 1.177M |
| Oct 23, 2026 | 44.15 | 44.15 | 43.15 | 43.63 | 884581.0 |
| Oct 22, 2026 | 44.00 | 44.69 | 43.00 | 44.18 | 1.834M |
| Oct 21, 2026 | 44.12 | 44.58 | 43.44 | 43.48 | 1.808M |
| Oct 20, 2026 | 43.38 | 45.20 | 43.20 | 44.11 | 2.202M |
| Oct 19, 2026 | 41.46 | 43.64 | 41.35 | 42.97 | 2.793M |
| Oct 16, 2026 | 40.18 | 41.57 | 39.71 | 41.22 | 3.408M |
| Oct 15, 2026 | 39.74 | 40.74 | 39.42 | 40.10 | 1.977M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amarin Corp. Plc | 11.25 |
| Prothena Corp. Plc | 8.41 |
| Cue Biopharma, Inc. | 4.56 |
| ACADIA Pharmaceuticals, Inc. | 17.59 |
| Alnylam Pharmaceuticals, Inc. | 147.82 |
Price Related Metrics
| PS Ratio | 4.516 |
| Price to Book Value | 4.163 |
| Price to Free Cash Flow | 34.83 |
| Earnings Yield | -0.03% |
| Market Cap | 7.763B |
| Operating PE Ratio | 85.44 |
| Normalized PE Ratio | 457.43 |